Cancer Biology

What causes cancer and how can we find better ways to treat it?

Improving melanoma treatment by blocking an enzyme
Cancer Biology

Improving melanoma treatment by blocking an enzyme

Study shows HPGDS plays a key role in immunotherapy resistance

Reprogramming immune cells to improve cancer treatment
Cancer Biology

Reprogramming immune cells to improve cancer treatment

Scientists at the VIB-KU Leuven Center for Cancer Biology and their collaborators demonstrated a remarkable ability to boost the immune system's fight against cancer

Researchers reveal why the lung is a frequent site of cancer metastasis
Cancer Biology

Researchers reveal why the lung is a frequent site of cancer metastasis

The availability of the amino acid aspartate is one reason why the lung is a frequent organ of metastasis

Does the menstrual cycle influence the effect of chemotherapy?
Cancer Biology

Does the menstrual cycle influence the effect of chemotherapy?

Researchers call for more women-specific drug research

Scientists discover how specific E. coli bacteria drive colon cancer
Immunity & Inflammation, Cancer Biology

Scientists discover how specific E. coli bacteria drive colon cancer

Certain E. coli bacteria in the gut promote colon cancer by binding to intestinal cells and releasing a DNA-damaging toxin

Menstrual cycle influences the spread of mutant cells in mammary tissue  
Cancer Biology

Menstrual cycle influences the spread of mutant cells in mammary tissue  

Researchers identify a key metabolic gene as target for improved cancer immunotherapy
Cancer Biology

Researchers identify a key metabolic gene as target for improved cancer immunotherapy

The CDA gene is among the top upregulated metabolic genes in immunotherapy-resistant tumors

Researchers map cell composition of metastatic melanoma and identify cause of immunotherapy resistance
Cancer Biology

Researchers map cell composition of metastatic melanoma and identify cause of immunotherapy resistance

Targeting mesenchymal-like melanoma cells could instigate immunotherapy response

Disabling autophagy can enhance immune response in melanoma
Cancer Biology

Disabling autophagy can enhance immune response in melanoma

Researchers discover that disabling autophagy in Tumor Endothelial Cells, inflames them and leads to a better immune response

Researchers discover cause of immunosuppressive behavior of regulatory T cells in cancer
Cancer Biology

Researchers discover cause of immunosuppressive behavior of regulatory T cells in cancer

Fucosylation – the addition of a fucose sugar to a molecule – has been identified as the driving force behind unbalanced Treg behavior in tumor microenvironment

New research shows insights into devastating metabolic disease
Cancer Biology

New research shows insights into devastating metabolic disease

Tracer metabolomics reveals the role of aldose reductase in glycosylation

Precursor of breast cancer or not?
Cancer Biology

Precursor of breast cancer or not?

New mouse model bridges 10-20 years of development of DCIS into breast cancer within one year

About VIB

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be